comparemela.com
Home
Live Updates
Immunic, Inc. Reports Year End 2021 Financial Results and Highlights Recent Activity : comparemela.com
Immunic, Inc. Reports Year End 2021 Financial Results and Highlights Recent Activity
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
Related Keywords
United States ,
Germany ,
Australia ,
New Zealand ,
German ,
Paula Schwartz ,
Edna Kaplan ,
Jessica Breu ,
Patrick Walsh ,
Daniel Vitt ,
Colitis Organization ,
Rx Communications Group ,
Nasdaq ,
Daiichi Sankyo Co Ltd ,
Exchange Commission ,
Development Rd Expenses ,
Ethics Committee ,
Immunic Inc ,
Chief Executive Officer ,
European Crohn ,
Received Notice ,
Patent Term Extension ,
Supplementary Protection Certificates ,
Appointed Patrick Walsh ,
Chief Business ,
Vidofludimus Calcium ,
Relapsing Remitting Multiple Sclerosis ,
Expanded Disability Status Scale ,
Settlement Agreement ,
German Federal Ministry ,
Cash Equivalents ,
Private Securities Litigation Reform Act ,
Annual Report ,
Investor Relations ,
Consolidated Statements ,
Ended December ,
Immunic ,
Nc ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Biotechnology ,
Pharmaceuticals ,
Earnings ,
comparemela.com © 2020. All Rights Reserved.